Dabigo contains the active ingredient Dabigatran, a blood thinner that lowers the chance of blood clots forming in your body. It helps:

   — Reduce the risk of stroke and blood clots in people who have a condition called atrial fibrillation. In the case of atrial fibrillation, part of the heart does not beat the way it should. This causes the formation of blood clots and increases your risk of a stroke.

   — Treat deep vein thrombosis (blood clots in the veins of your legs) or pulmonary embolism (blood clots in the veins of your lungs) and reduce the risk of them occurring again.

   — Prevent blood clots in the legs and lungs of people who have just had hip replacement surgery.

Dabigo is not recommended for people with artificial heart valves. It is not known if Dabigatran is safe and effective in children. 

Dabigo capsules can be taken before or after consuming food. You may need to take medicine for many years, even for the rest of your life in some cases. Do not stop treatment without your doctor’s approval. It could quickly put at high risk of having a stroke, heart attack, or thrombosis (formation of a blood clot within a blood vessel). You can reduce your risk of having a blood clot by making certain lifestyle changes such as eating a healthy diet, exercising regularly, not smoking, and weight management. 

Do not take Dabigo 150 if you have severe liver or kidney problems, are bleeding, or are taking other medicines to reduce blood clotting. You should not breastfeed while taking medicine. You should not breastfeed while taking this blood thinner. Tell your doctor if you are taking other medicine supplements or herbal products. Certain medications such as ketoconazole, dronedarone, cyclosporine, and antiviral medicines such as glecaprevir should not be taken with Dabigatran. Concomitant use of tacrolimus and digoxin is not recommended with Dabigatran. Caution should be taken in case of concomitant use of certain medications such as amiodarone, quinidine, clarithromycin, and posaconazole. Taking other anticoagulants with Dabigatran may increase the risk of bleeding. Concomitant use of drugs such as rifampicin, carbamazepine or phenytoin should be avoided. The effects of this anticoagulant drug on pregnancy and the growing child are unknown. Therefore, you should not take medicine during pregnancy unless your doctor advises that it is safe. Women should avoid getting pregnant during the treatment.

The most common side effect of Dabigo is an upset stomach and bleeding more easily than normal (nosebleeds or bruising). If you develop any symptoms, tell your doctor immediately. Other side effects include seizures, headaches, tiredness, changes to your eyesight, and allergic reactions.